Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY Business Segments — Investment Income Nonoperating

Similar metrics at other companies

Williams Companies logo
WMBInvestment Income Nonoperating Other
$0+100%
Riot Platforms, Inc. logo
RIOTOther Nonoperating Income
$2.31M-31.9%
ANI Pharmaceuticals logo
ANIPRare Disease and Brands — Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
$36.25M+71.5%
Imperial Oil logo
IMOInvestment And Other Income Net
$30M-41.2%
Edgewise Therapeutics, Inc. logo
EWTXOther Nonoperating Income
$5.1M-1.1%
Sionna Therapeutics, Inc. Common Stock logo
SIONOther Nonoperating Income
$0-100%

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeNonoperating.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s business segments — investment income nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s business segments — investment income nonoperating?
Harmony Biosciences Holdings, Inc. (HRMY) reported business segments — investment income nonoperating of $5.76M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s business segments — investment income nonoperating changed year-over-year?
Harmony Biosciences Holdings, Inc.'s business segments — investment income nonoperating increased by 14.1% year-over-year, from $5.04M to $5.76M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s business segments — investment income nonoperating?
Over 3 years (2022 to 2025), Harmony Biosciences Holdings, Inc.'s business segments — investment income nonoperating has grown at a 91.4% compound annual growth rate (CAGR), from $3.13M to $21.92M.
What does business segments — investment income nonoperating mean?
This captures the income generated from cash reserves, marketable securities, or other financial investments held by the company. It reflects the efficiency of the company's treasury management and the returns on its non-operating liquid assets.